10x Genomics Inc. (TXG)
NASDAQ: TXG
· Real-Time Price · USD
13.52
0.28 (2.11%)
At close: Aug 15, 2025, 12:41 PM
10x Genomics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 397.71M | 377.06M | 344.07M | 398.16M | 379.82M | 355.78M | 359.28M | 311.26M | 325.88M | 332.32M | 219.75M | 233.95M | 274.19M | 312.49M | 587.45M | 600.44M | 621.96M | 617.2M |
Short-Term Investments | 49.55M | 49.84M | 49.34M | n/a | 269K | 16.03M | 29.41M | 45.64M | 65.51M | 85.97M | 210.24M | 218.44M | 225.55M | 226.84M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.47M | 4.97M | 4.97M | 7.09M | 7.09M | 7.6M | 7.6M | 8.6M | 8.6M | 8.6M |
Other Long-Term Assets | 2.67M | 2.3M | 4.13M | 4.9M | 5.19M | 2.84M | 3.06M | 8.62M | 23.93M | 17.83M | 7.37M | 9.99M | 10.29M | 10.76M | 10.92M | 38.65M | 39.44M | 40.14M |
Receivables | 119.07M | 52.55M | 87.86M | 83.53M | 91.18M | 91.31M | 114.83M | 103.85M | 87.69M | 77.94M | 104.21M | 83.55M | 76.2M | 76.53M | 85.25M | 78.43M | 59.68M | 57.41M |
Inventory | 68.97M | 74.71M | 83.11M | 94.05M | 88.27M | 83.19M | 73.71M | 80.92M | 83.69M | 82.31M | 81.63M | 78.63M | 70.65M | 63.7M | 59.97M | 51.14M | 44.09M | 38.51M |
Other Current Assets | 20.36M | 25.57M | 20.02M | 18.16M | 19.61M | 20.79M | 18.79M | 20.68M | 20.18M | 23.36M | 19.21M | 508K | 508K | 17.79M | 1.03M | 28K | 18.15M | 18.16M |
Total Current Assets | 655.66M | 579.73M | 584.39M | 593.89M | 579.15M | 567.09M | 596.02M | 562.35M | 582.94M | 601.89M | 635.03M | 629.42M | 666.23M | 697.34M | 747.59M | 744.1M | 757.17M | 745.72M |
Property-Plant & Equipment | 302.41M | 301.66M | 309.94M | 318.34M | 324.16M | 332.34M | 344.93M | 354.2M | 355.96M | 366.84M | 359.21M | 328.79M | 296.43M | 265.88M | 230.41M | 203.3M | 176.45M | 163.67M |
Goodwill & Intangibles | 19.23M | 19.7M | 20.18M | 20.66M | 21.17M | 20.64M | 21.13M | 26.34M | 26.8M | 27.46M | 27.37M | 28M | 28.64M | 29.27M | 29.91M | 4.51M | 4.51M | 4.51M |
Total Long-Term Assets | 324.31M | 323.66M | 334.25M | 343.9M | 350.51M | 355.82M | 369.12M | 386.19M | 406.7M | 412.14M | 393.94M | 366.79M | 335.36M | 305.92M | 271.24M | 246.47M | 220.41M | 208.32M |
Total Assets | 979.97M | 903.39M | 918.64M | 937.79M | 929.67M | 922.91M | 965.14M | 948.54M | 989.64M | 1.01B | 1.03B | 996.21M | 1B | 1B | 1.02B | 990.57M | 977.58M | 954.03M |
Account Payables | 15.94M | 10.07M | 12.91M | 26.21M | 21.25M | 20.22M | 15.74M | 18.84M | 23.12M | 29.32M | 21.6M | 21.59M | 26.73M | 18.96M | 17.35M | 17.04M | 16.18M | 15.58M |
Deferred Revenue | 21.45M | 20.95M | 20.66M | 17.76M | 16.44M | 14.3M | 13.15M | 11.14M | 9.22M | 8.53M | 7.87M | 6.67M | 6.47M | 5.43M | 5.34M | 5.5M | 5.27M | 4.48M |
Short-Term Debt | 9.67M | n/a | n/a | n/a | n/a | 11.13M | 11.52M | 10.01M | 9.29M | 9.2M | n/a | 8.39M | 7.98M | 7.64M | n/a | 4.46M | 4.91M | 6.16M |
Other Current Liabilities | 34.09M | 34.13M | 41.84M | 34.38M | 36.65M | 25.52M | 40.08M | 22.56M | 22.48M | 35.89M | 29.74M | 50.48M | 43.8M | 34.55M | 46.29M | 38.42M | 56.55M | 68.88M |
Total Current Liabilities | 112.22M | 107.9M | 117.63M | 121.23M | 111.02M | 108.73M | 127.16M | 104.72M | 98.09M | 112.01M | 130.96M | 126.86M | 117.91M | 94.45M | 110.36M | 100.38M | 113.13M | 120.55M |
Long-Term Debt | 77.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 90.33M | 92.84M | n/a | 87.83M | 91.04M | 93.54M | n/a | 75.73M | 65.92M | n/a |
Other Long-Term Liabilities | 6.13M | 5.4M | 5.03M | 4.95M | 4.57M | 4.51M | 4.28M | 10.14M | -82.41M | -86.05M | 6.14M | -82.11M | -81.91M | -84.96M | 14.05M | -61.49M | -51.97M | 14.68M |
Total Long-Term Liabilities | 94.47M | 88.6M | 90.87M | 93.75M | 94.59M | 95.35M | 96.94M | 98.61M | 98.25M | 99.64M | 92.28M | 93.56M | 100.17M | 102.12M | 90.9M | 89.98M | 79.87M | 81.02M |
Total Liabilities | 206.69M | 196.5M | 208.5M | 214.99M | 205.61M | 204.08M | 224.1M | 203.32M | 196.34M | 211.65M | 223.24M | 220.41M | 218.07M | 196.57M | 201.26M | 190.35M | 192.99M | 201.57M |
Total Debt | 86.74M | 80.07M | 82.61M | 85.88M | 89.48M | 92.18M | 95.37M | 98.47M | 99.62M | 102.04M | 95.18M | 96.23M | 99.02M | 101.17M | 81.98M | 80.2M | 70.82M | 72.5M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -1.47B | -1.5B | -1.47B | -1.42B | -1.38B | -1.34B | -1.28B | -1.24B | -1.14B | -1.08B | -1.03B | -1.01B | -970.19M | -905.73M | -863.32M | -844.87M | -827.7M | -816.65M |
Comprehensive Income | 220K | -367K | -493K | 32K | -430K | -456K | -429K | -677K | -969K | -1.48M | -4.33M | -5.49M | -3.96M | -2.44M | 22K | 194K | 58K | 48K |
Shareholders Equity | 773.28M | 706.89M | 710.13M | 722.8M | 724.06M | 718.83M | 741.04M | 745.22M | 793.3M | 802.38M | 805.74M | 775.79M | 783.52M | 806.68M | 817.57M | 800.22M | 784.59M | 752.46M |
Total Investments | 49.55M | 49.84M | 49.34M | n/a | 269K | 16.03M | 29.41M | 45.64M | 65.51M | 85.97M | 210.24M | 218.44M | 225.55M | 226.84M | 7.6M | 8.6M | 8.6M | 8.6M |